
Amanhã, maiores avanços no diagnóstico, tratamento e prevenção da doença de Alzheimer e outras demências. Gratuito, com coffee, almoço e certificados :) Vejo vocês lá! simpcentrodamemoria.eventize…

professor, clinician-scientist, neurologist. interested in cognitive reserve and glia. @borelli_lab @alzassociation @ufrgsnoticias

Amanhã, maiores avanços no diagnóstico, tratamento e prevenção da doença de Alzheimer e outras demências. Gratuito, com coffee, almoço e certificados :) Vejo vocês lá! simpcentrodamemoria.eventize…

You never forget your first time 💚 The @borelli_lab team is heading for the first time to #AAIC2025, the world’s biggest event on Alzheimer’s and dementia research! We’ve won travel awards to share our science from 🇧🇷 🗓 July 27–31 | 📍Toronto 🇨🇦 Check out our presentations!

In a world facing political turmoil, social exposomes, and pollution, our study reveals that these forces accelerate aging. BBAGs can help spot risks early and guide actions for healthier aging worldwide. Congrats @HernHdezL, @SandraBez9, @nanosanta & collegues: Sebastian Moguilner, Francesca Farina, @AgustinaLegaz @PavelPradoG Jhosmary Cuadros, Liset Gonzalez, @rglezgz @joaquin_migeot Carlos Coronel-Oliveros, @ETagliazucchi @MarceloMaito @godoymeugenia @josecruzat Ahmed Shaheen @DrTFarombi Daniel Salazar @DaUglione @vbwyll @erzimmer Alfred K. Njamnshi, Swati Bajpai A Dey, Cyprian Mostert, Zul Merali, @Mohamed03966736 Sara Moustafa @SolFittipaldi Florencia Altschuler, @medelero @DavidHuepe @KristineYaffe @MomohChi @HarrisAEyre @pswieboda @ProfLawlor @jjaimemiranda @durananiotz 6/6🧵

Dr. @vbwyll in action at @congressobrain, presenting on blood biomarkers for Alzheimer’s disease 🧠🩸 — discussing when and how to implement them in clinical practice. An important step toward more accessible and earlier diagnosis.

Excited to announce this new step! 🧠
👋 Hello, nice to meet you — we’re just getting started! We are a research group led by Dr. @vbwyll, dedicated to studying Alzheimer’s and related dementias 🧠 Our mission: advance prevention, early diagnosis, and treatment through neuroscience!


GLP-1 agonists seem to benefit individuals with abusive behavior - food intake, alcohol, drugs. Will it work in #AD?
GLP-1 agonists semaglutide and liraglutide may be effective in the treatment of alcohol use disorder. ja.ma/3O4GAsr

There’s no doubt that anti-amyloid will increase health discrepancy - the discussion is about the next steps. Great discussion on Leqembi, UK, Japan and the recent European decision: alzforum.org/news/conference…

Wanna hear about blood-based biomarkers in LMIC and their clinical implementation? Check our webinar hosted by @ISTAART PIA Real World Translation Work Group. 👇

Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country with significant challenges. I am glad to have led this task force with colleagues and mentors. Articles available at @DementiaNeuro (links below)


It’s amazing to hear an inspiring, brilliant researcher that encourage the whole Brazilian community to keep researching.
The spectacular @grinberg_t explaining why we should study sleep in brain aging and dementia at #CBN2024 😴💤🛌🥱

Precision brain health can evolve by integrating computational frameworks of brain clocks + multimodal diversity, showing how inequities and exposomes impact brain health. Out in @NatureMedicine, written with editors & the great @SandraBez9 + @vbwyll 👉doi.org/10.1038/s41591-024-0…

Part of the task force that published the guidelines for the use of AD biomarkers and potential use of anti-amyloid therapies in Brazil. It was an honor to work with the greatest references in this field in Brazil

Glad to contribute with the national consensus.
Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country with significant challenges. I am glad to have led this task force with colleagues and mentors. Articles available at @DementiaNeuro (links below)

Palestra incrível do @leandrominozzo sobre a política nacional de cuidado integral a pessoas com doença de Alzheimer e outras demências. Muita coisa boa para celebrar! @erzimmer e #nitrini em foco